Accera, Boulder, Colo., Assigned Patent for Use of Medium Chain Triglycerides for Treatment, Prevention of Alzheimer's Disease
Copyright © Targeted News Service, 2017
2017-03-29
Copyright © Targeted News Service, 2017
2017-03-29
ALEXANDRIA, Va., March 29 -- Accera, Boulder, Colorado, has been assigned a patent (9,603,823) developed by Samuel T. Henderson, Golden, Colorado, for the "use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II."
The patent application was filed on April 9, 2013 (13/859,608). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITO . . .
The patent application was filed on April 9, 2013 (13/859,608). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITO . . .